Glassy Mountain Advisors Inc. acquired a new position in HCA Healthcare, Inc. (NYSE:HCA – Free Report) during the third quarter, HoldingsChannel reports. The institutional investor acquired 8,397 shares of the company’s stock, valued at approximately $3,413,000. HCA Healthcare makes up about 1.2% of Glassy Mountain Advisors Inc.’s holdings, making the stock its 29th biggest position.
Other large investors have also recently made changes to their positions in the company. MFA Wealth Advisors LLC bought a new stake in shares of HCA Healthcare in the 2nd quarter worth approximately $27,000. Unique Wealth Strategies LLC bought a new stake in shares of HCA Healthcare during the second quarter valued at approximately $28,000. Bangor Savings Bank boosted its position in shares of HCA Healthcare by 112.5% during the second quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after purchasing an additional 45 shares in the last quarter. GPS Wealth Strategies Group LLC boosted its position in shares of HCA Healthcare by 284.0% during the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after purchasing an additional 71 shares in the last quarter. Finally, Benjamin F. Edwards & Company Inc. bought a new stake in shares of HCA Healthcare during the second quarter valued at approximately $33,000. 62.73% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
Several equities research analysts recently weighed in on the company. Wolfe Research upgraded HCA Healthcare to a “strong-buy” rating in a research report on Thursday, August 29th. Morgan Stanley started coverage on HCA Healthcare in a report on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 target price on the stock. UBS Group boosted their target price on HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a report on Wednesday, August 14th. TD Cowen dropped their target price on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a report on Monday, October 28th. Finally, Oppenheimer boosted their target price on HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a report on Monday, October 28th. Five equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and three have given a strong buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $379.11.
HCA Healthcare Stock Down 0.4 %
HCA Healthcare stock opened at $357.19 on Friday. The stock has a market cap of $92.18 billion, a PE ratio of 16.04, a price-to-earnings-growth ratio of 1.37 and a beta of 1.68. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. HCA Healthcare, Inc. has a one year low of $225.32 and a one year high of $417.14. The stock has a fifty day moving average of $392.99 and a 200 day moving average of $354.47.
HCA Healthcare Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be issued a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a yield of 0.74%. The ex-dividend date is Friday, December 13th. HCA Healthcare’s dividend payout ratio is presently 11.85%.
Insider Buying and Selling at HCA Healthcare
In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the sale, the executive vice president now owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. 1.60% of the stock is currently owned by corporate insiders.
HCA Healthcare Company Profile
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
See Also
- Five stocks we like better than HCA Healthcare
- Why Are Stock Sectors Important to Successful Investing?
- From PACs to Portfolios: Billionaire Bets and Investor Reactions
- Utilities Stocks Explained – How and Why to Invest in Utilities
- AppLovin Stock Quadruples: What’s Behind the Bullish Sentiment?
- Retail Stocks Investing, Explained
- Battle of the Retailers: Who Comes Out on Top?
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.